Aug 1 (Reuters) - ReproCell Inc 4978.T :
* Says its 71.6 percent owned subsidiary, Bioserve
Biotehnologies, Ltd., will merge with two other wholly owned
subsidiaries, Stemgent Inc. and Biopta Inc.
* Says after the transaction, Bioserve Biotehnologies, Ltd.
will be the surviving company, Stemgent Inc. and Biopta Inc.
will be dissolved
* Bioserve Biotehnologies, Ltd. will change company name
into ReproCELL U.S.A. Inc., and ReproCell will hold 92.55
percent stake in ReproCELL U.S.A.
* Effective date Sep. 1
Source text in Japanese: https://goo.gl/5kny29
Further company coverage: 4978.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: ying.zhao.reuters.com@reuters.net))